Government initiatives for large scale DNA sequencing-based projects, collaborations for technical advancements, and declining costs are key factors driving the market demand.

Market Size – USD 4.77 Billion in 2019, Market Growth - CAGR of 11.3%, Market Trends –Advancement in technology.

The global DNA Sequencing Market is forecasted to reach USD 11.28 Billion by 2027, according to a new report by Reports and Data. The market for DNA sequencing is experiencing high demand owing to its applications in biomarker discovery, personalized medicine, oncology studies, forensics, and others. Its demand has increased due to a surge in sequencing applications and advancement in technology in DNA sequencing. Growth in R&D investment is also encouraging the growth of the market.

Other factors propelling the demand for the market are growing partnerships and collaboration among market players and a rise in genome mapping programs all across the globe. Increased investment in research and development activities provides a lucrative opportunity for the industry. However, standardization concerns and legal & ethical limitations accredited with DNA sequencing hamper the demand for the market.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/3705

The COVID-19 impact:

The distribution of Covid-19's has influenced industrial activities worldwide. Pharma company manufacturers are at the forefront of human response to the COVID-19 pandemic. An increase in the number of biotech firms to explore and develop a vaccine for the virus has developed a strict competition. DNA sequencing is playing a crucial role in the development of therapies for chronic diseases at an unprecedented rate, and a substantial amount of funds are being put into the research and development of the market product. The market will witness an increased demand in the coming years.

Further key findings from the report suggest

· The consumables segment held the largest share due to the wide availability of kits and reagents to cater to DNA fragmentation, amplification, fragmentation enrichment, and quality control, which contributes to the growth of the product and services segment.

· Next-Generation Sequencing (NGS) is anticipated to witness diversification into a substantial number of clinical areas due to the reduction in cost. At present, next-generation sequencing is acknowledged to be the leading technology responsible for the burgeoning field of oncology, Mendelian diseases, and complex disease testing.

· Pharmaceutical companies are making use of the available genomic information in personalized medicine, which is forecasted to significantly impact the growth of the market. The reduction in the cost of sequencing has made it more attractive to pharmaceutical and biotechnology companies.

· North America remains the key revenue-generating geographical segment in the DNA sequencing market. The availability of research funds from the public as well as private sources, availability of state-of-art technologies, and presence of key market players in the region are among the key factors driving the market growth in this region.

· Key participants include Thermo Fisher Scientific, Inc., Agilent Technologies, QIAGEN, Illumina, Inc., F. Hoffmann-La Roche Ltd., Macrogen, Inc., Oxford Nanopore Technologies, Pacific Biosciences Of California, Inc., Perkin Elmer, Inc., and Bio-Rad Laboratories, Inc., among others.

To know more about the report @ https://www.reportsanddata.com/report-detail/dna-sequencing-market

For the purpose of this report, Reports and Data has segmented into the Global DNA Sequencing Market on the basis of product and services, technology, application, end-user, and region:

Product and Services Outlook (Revenue, USD Billion; 2017-2027)

· Consumables

· Instruments

· Services

Technology Outlook (Revenue, USD Billion; 2017-2027)

· Next-Generation Sequencing

o Whole Genome Sequencing

o Whole Exome Sequencing

o Targeted Sequencing & Resequencing

· Sanger Sequencing

· Third-Generation Sequencing

o Single-molecule real-time sequencing (SMRT)

o Nanopore sequencing

Application Outlook (Revenue, USD Billion; 2017-2027)

· Reproductive Health

· Oncology

· Agrigenomics & Forensics

· Clinical Investigation

· Metagenomics, Epidemiology & Drug Development

· HLA Typing/Immune System Monitoring

· Consumer Genomics

· Others

End-User Outlook (Revenue, USD Billion; 2017-2027)

· Pharmaceutical & Biotechnology Companies

· Hospitals and Clinics

· Clinical Research

· Academic Research

Regional Outlook (Revenue, USD Billion; 2017-2027)

· North America

o U.S

o Canada

· Europe

o Germany

o U.K

o France

o BENELUX

o Rest of Europe

· Asia Pacific

o China

o Japan

o South Korea

o Rest of APAC

· MEA

o Saudi Arabia

o UAE

o Rest of MEA

· Latin America

o Brazil

o Rest of LATAM

Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/3705

Overview of the TOC of the Report:

· Chapter 1: Industry Overview including segmentation and drivers

· Chapter 2: Competitive landscape

· Chapter 3: Regional Analysis of Production and Consumption

· Chapter 4: Revenue and Market share by types

· Chapter 5: Consumption outline by applications including market share and growth rate

· Chapter 6: Profiling of manufacturers and key players

· Chapter 7: Production and manufacturing cost analysis

· Chapter 8: Supply chain analysis, market strategy analysis, and sourcing strategy

· Chapter 9: Market forecast

· Chapter 10: Conclusion of the research findings

Thank you for reading our report. Customization of the report is available based on the client’s requirements. For more details, kindly connect with us, and our team will ensure the report is suited to meet your requirements.

Browse More Reports:

Preimplantation Genetic Testing Market Size

Computational Biology Market Share